Adma Biologics (ADMA) Debt Ratio (2012 - 2025)

Adma Biologics' Debt Ratio history runs 13 years deep, the most recent figure standing at 0.12 for Q4 2025.

• Quarterly Debt Ratio fell 21.93% year-over-year to 0.12 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.12 (down 21.93% YoY) and the FY2025 annual result came in at 0.12, down 21.93% from the prior year.
• Debt Ratio was 0.12 for Q4 2025 at Adma Biologics, down from 0.13 in the prior quarter.
• Across five years, Debt Ratio topped out at 0.47 in Q2 2022 and bottomed at 0.12 in Q4 2025.
• A 5-year average of 0.33 and a median of 0.4 in 2021 frame the typical range for Debt Ratio.
• Annual changes were most pronounced in 2022 — Debt Ratio rose 19.36% — and 2024, when it plunged 62.69%.
• Adma Biologics' Debt Ratio stood at 0.34 in 2021, then climbed by 19.36% to 0.41 in 2022, then slipped by 3.21% to 0.4 in 2023, then plunged by 62.69% to 0.15 in 2024, then dropped by 21.93% to 0.12 in 2025.
• Business Quant data shows ADMA's Debt Ratio at 0.12 in Q4 2025, 0.13 in Q3 2025, and 0.13 in Q2 2025.